Compare HUN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUN | RLAY |
|---|---|---|
| Founded | 1970 | 2015 |
| Country | United States | United States |
| Employees | 6300 | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 2004 | 2020 |
| Metric | HUN | RLAY |
|---|---|---|
| Price | $15.10 | $12.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | $12.09 | ★ $19.50 |
| AVG Volume (30 Days) | ★ 4.9M | 3.1M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.64% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,683,000,000.00 | $15,355,000.00 |
| Revenue This Year | $3.08 | N/A |
| Revenue Next Year | $5.27 | $324.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $7.30 | $2.71 |
| 52 Week High | $15.90 | $17.32 |
| Indicator | HUN | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 66.14 | 45.12 |
| Support Level | $13.10 | $6.67 |
| Resistance Level | N/A | $17.32 |
| Average True Range (ATR) | 0.76 | 1.02 |
| MACD | 0.10 | -0.47 |
| Stochastic Oscillator | 72.01 | 19.21 |
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.